SB431542 treatment promotes the hypertrophy of skeletal muscle fibers but decreases specific force

Muscle and Nerve

Volumn 41, Issue 5, 2010, Pages 624-629

  Watt, Kevin I ^a   Jaspers, Richard T ^c   Atherton, Phillip ^b   Smith, Ken ^b   Rennie, Michael J ^b   Ratkevicius, Aivaras ^a   Wackerhage, Henning ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Hypertrophy; Myostatin; SB431542; Skeletal muscle; Smad

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; MYOGENIN; MYOSIN HEAVY CHAIN; MYOSTATIN; S6 KINASE; SMAD2 PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; MOUSE; MUSCLE CELL; MUSCLE FORCE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TISSUE CULTURE; XENOPUS;

ANIMALS; BENZAMIDES; CELL LINE; CELL SIZE; CELLS, CULTURED; DIOXOLES; HYPERTROPHY; MICE; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS; MYOSTATIN; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; XENOPUS LAEVIS;

EID: 77951280181     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21573     Document Type: Article

References (36)

1. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387:83-90.
2. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997;94: 12457-12461.
3. Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genetics 2007;3:779-786. (Pubitemid 46833955)
4. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al. Brief report - myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682-2688. (Pubitemid 38788003)
5. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004;20:61-86.
6. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 2001;98:9306-9311. (Pubitemid 32743912)
7. Hill JJ, Qiu YC, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol 2003;17:1144-1154.
8. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002;277:40735-40741.
9. Bogdanovich S, Krag TOB, Barton ER, Morris LD, Whittemore LA, Ahima RS, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;420:418-421. (Pubitemid 35415652)
10. Whittemore LA, Song KN, Li XP, Aghajanian J, Davies M, Girgenrath S, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003;300: 965-971. (Pubitemid 36262030)
11. Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve 2009;39:283-296.
12. Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 2008;22:477-487. (Pubitemid 351225584)
13. Qiao CP, Li JB, Jiang JG, Zhu XD, Wang B, Li J, et al. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum Gene Ther 2008;19:241B-254B. (Pubitemid 351442731)
14. Wagner KR, Fleckenstein JL, Amato AA, Barohn RJ, Bushby K, Escolar DM, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008;63:561-571.
15. Krivickas LS, Walsh R, Amato AA. Single muscle fiber contractile properties in adults with muscular dystrophy treated with myo-029. Muscle Nerve 2009;39:3-9.
16. Lee S. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS ONE 2007;2:e789. (Pubitemid 351377327)
17. Lee SJ, Reed LA, Davies MV, Girgenrath S, Goad MEP, Tomkinson KN, et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci U S A 2005;102:18117-18122. (Pubitemid 41798511)
18. Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, et al. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 2009;217:258-268.
19. Jaspers RT, Feenstra HM, Lee-de Groot MBE, Huijing PA, van der Laarse WJ. Twitch and tetanic tension during culture of mature xenopus laevis single muscle fibers. Arch Physiol. Biochem 2001;109:410-417.
20. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, et al. Inhibition of transforming growth factor (TGF)-beta 1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002;62:58-64. (Pubitemid 34680516)
21. Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK. Activin A mediates growth inhibition and cell cycle arrest through smads in human breast cancer cells. Cancer Res 2005;65:7968-7975. (Pubitemid 41297276)
22. Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, et al. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res 2007;67:2317-2324. (Pubitemid 46424252)
23. Tai T, Chan C, Lin C, Chen L, Jeng J, Chang M. Transforming growth factor beta 2 regulates growth and differentiation of pulp cells via ALK5/Smad2/3. J Endod 2008;34:427-432.
24. Ho DM, Chan J, Bayliss P, Whitman M. Inhibitor-resistant type I receptors reveal specific requirements for TGF-beta signaling in vivo. Dev Biol 2006;295:730-742. (Pubitemid 43927706)
25. Sartori R, Milan G, Patron M, Mammucari C, Blaauw B, Abraham R, et al. Smad2 and 3 transcription factors control skeletal muscle mass in adulthood. Am J Physiol Cell Physiol 2009;296:C1248-C1257.
26. Welle S, Burgess K, Mehta S. Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. Am J Physiol Endocrinol Metab 2009;296:E567-E572.
27. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 2006;101:898-905.
28. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci U S A 2007;104:1835-1840. (Pubitemid 46239865)
29. Arnold HH, Braun T. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: a review. Int J Dev Biol 1996;40:345-353. (Pubitemid 26151279)
30. Hasty P, Bradley A, Morris JH, Edmondson DG, Venuti JM, Olson EN, et al. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993;364:501-506. (Pubitemid 23273093)
31. Nabeshima Y, Esumi E, Arahata K, Nonaka I, Hayasaka M, Hanaoka K, et alMyogenin gene disruption leads to developmental abnormalities in myogenic lineage cells. J Cell Biochem 1994;469-469
32. Dardevet D, Sornet C, Vary T, Grizard J. Phosphatidylinositol 3-kinase and p70 S6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 1996;137:4087-4094. (Pubitemid 26321849)
33. Trendelenburg A, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass D. Myostatin reduces Akt/TORC1/p70 S6k signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 2009;296:C1258- C1270.
34. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001;280:E221-E228.
35. Jaspers RT, van Beek-Harmsen BJ, Blankenstein MA, Goldspink G, Huijing PA, van der Laarse WJ. Hypertrophy of mature Xenopus muscle fibers in culture induced by synergy of albumin and insulin. Pflugers Arch 2008;457:161-170.
36. Inman G, Nicolás F, Callahan J, Harling J, Gaster L, Reith A, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002;62:65-74. (Pubitemid 34680517)